Your browser doesn't support javascript.
loading
Early Detection of Multiple Resistance Mechanisms by ctDNA Profiling in a Patient With EGFR-mutant Lung Adenocarcinoma Treated With Osimertinib.
Schmid, Sabine; Stewart, Erin L; Martins-Filho, Sebastiao N; Cabanero, Michael; Wang, Ao; Bao, Hua; Wu, Xue; Patel, Deval; Chen, Zhuo; Law, Jennifer H; Bradbury, Penelope A; Shepherd, Frances A; Leighl, Natasha; Tsao, Ming-Sound; Pugh, Trevor; Bratman, Scott V; Sacher, Adrian; Liu, Geoffrey.
Afiliación
  • Schmid S; University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Stewart EL; University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Martins-Filho SN; University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
  • Cabanero M; University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
  • Wang A; Translational Medicine Research Institute, Geneseeq Technology Inc, Toronto, ON, Canada.
  • Bao H; Translational Medicine Research Institute, Geneseeq Technology Inc, Toronto, ON, Canada.
  • Wu X; Translational Medicine Research Institute, Geneseeq Technology Inc, Toronto, ON, Canada.
  • Patel D; University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Chen Z; University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Law JH; University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Bradbury PA; University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Shepherd FA; University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Leighl N; University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Tsao MS; University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
  • Pugh T; University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
  • Bratman SV; University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.
  • Sacher A; University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada; Department of Medicine, University of Toronto, Toronto, ON, Canada.
  • Liu G; University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada; Department of Medicine, University of To
Clin Lung Cancer ; 21(5): e488-e492, 2020 09.
Article en En | MEDLINE | ID: mdl-32389504
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Acrilamidas / Biomarcadores de Tumor / Resistencia a Antineoplásicos / ADN Tumoral Circulante / Adenocarcinoma del Pulmón / Compuestos de Anilina / Mutación Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Clin Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Acrilamidas / Biomarcadores de Tumor / Resistencia a Antineoplásicos / ADN Tumoral Circulante / Adenocarcinoma del Pulmón / Compuestos de Anilina / Mutación Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Clin Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos